Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat
Background: Parkinson’s disease is a neurodegenerative disease of dopaminergic neurons in substancia nigra. Superoxides formation is one of the main etiologies of the disease, and angiotensin converting enzyme inhibitors (ACEIs) are able to suppress superoxide formation. Objective: Berberis vulgaris...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Institue of Medicinal Plants, ACECR
2010-12-01
|
Series: | Journal of Medicinal Plants |
Subjects: | |
Online Access: | http://jmp.ir/article-1-241-en.html |
id |
doaj-298b22dec85e42478cbe09eae9660a90 |
---|---|
record_format |
Article |
spelling |
doaj-298b22dec85e42478cbe09eae9660a902021-09-19T04:27:55ZengInstitue of Medicinal Plants, ACECRJournal of Medicinal Plants2717-204X2717-20582010-12-019362433Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in RatF Salar0SA Ziai1S Nasri2M Roghani3M Kamalinejad4 1- Department of Biology, Payam Noor University 2- Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences 3- Department of Biology, Payam Noor University 4- Department of Pharmacology, School of Medicine, Shahed University 5- Department of Pharmacognosy, School of Pharmacy, Shaheed Beheshti University of Medical Sciences Background: Parkinson’s disease is a neurodegenerative disease of dopaminergic neurons in substancia nigra. Superoxides formation is one of the main etiologies of the disease, and angiotensin converting enzyme inhibitors (ACEIs) are able to suppress superoxide formation. Objective: Berberis vulgaris is an ACE inhibitor and considered for this purpose. Methods: Male rats (n=32) were divided in 4 groups: Sham, Neurotoxin (injection of 6-hydroxydopamine into left hemisphere SNC), Berberis vulgaris aqueous extract (10 mg/kg) and captopril. Berberis and captopril were injected i.p. 7 days before and 3 days after 6-hydroxydopamine injection. Muscle rigidity, apomorphine test, brain protein oxidation and lipid peroxidation as well as serum and brain ACE activity were assayed in all 4 groups. Results: Rotation test with apomorphine in captopril and Berberis groups were significantly lower than neurotoxin group (p=0.002). Lipid peroxidation in captopril was significantly lower than neurotoxin (p=0.013). Captopril and Berberis both inhibited serum ACE activity respectively, but Berberis inhibited brain ACE too. Conclusion: Berberis vulgaris aqueous extract is an ACE inhibitor with anti-parkinsonism effect and should be studied more.http://jmp.ir/article-1-241-en.htmlberberis vulgarisparkinson’s disease6-ohdaangiotensin converting enzyme |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
F Salar SA Ziai S Nasri M Roghani M Kamalinejad |
spellingShingle |
F Salar SA Ziai S Nasri M Roghani M Kamalinejad Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat Journal of Medicinal Plants berberis vulgaris parkinson’s disease 6-ohda angiotensin converting enzyme |
author_facet |
F Salar SA Ziai S Nasri M Roghani M Kamalinejad |
author_sort |
F Salar |
title |
Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat |
title_short |
Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat |
title_full |
Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat |
title_fullStr |
Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat |
title_full_unstemmed |
Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat |
title_sort |
neuroprotective effect of aqueous extract of berberis vulgaris l. in a model of parkinson’s disease in rat |
publisher |
Institue of Medicinal Plants, ACECR |
series |
Journal of Medicinal Plants |
issn |
2717-204X 2717-2058 |
publishDate |
2010-12-01 |
description |
Background: Parkinson’s disease is a neurodegenerative disease of dopaminergic neurons in substancia nigra. Superoxides formation is one of the main etiologies of the disease, and angiotensin converting enzyme inhibitors (ACEIs) are able to suppress superoxide formation. Objective: Berberis vulgaris is an ACE inhibitor and considered for this purpose. Methods: Male rats (n=32) were divided in 4 groups: Sham, Neurotoxin (injection of 6-hydroxydopamine into left hemisphere SNC), Berberis vulgaris aqueous extract (10 mg/kg) and captopril. Berberis and captopril were injected i.p. 7 days before and 3 days after 6-hydroxydopamine injection. Muscle rigidity, apomorphine test, brain protein oxidation and lipid peroxidation as well as serum and brain ACE activity were assayed in all 4 groups. Results: Rotation test with apomorphine in captopril and Berberis groups were significantly lower than neurotoxin group (p=0.002). Lipid peroxidation in captopril was significantly lower than neurotoxin (p=0.013). Captopril and Berberis both inhibited serum ACE activity respectively, but Berberis inhibited brain ACE too. Conclusion: Berberis vulgaris aqueous extract is an ACE inhibitor with anti-parkinsonism effect and should be studied more. |
topic |
berberis vulgaris parkinson’s disease 6-ohda angiotensin converting enzyme |
url |
http://jmp.ir/article-1-241-en.html |
work_keys_str_mv |
AT fsalar neuroprotectiveeffectofaqueousextractofberberisvulgarislinamodelofparkinsonsdiseaseinrat AT saziai neuroprotectiveeffectofaqueousextractofberberisvulgarislinamodelofparkinsonsdiseaseinrat AT snasri neuroprotectiveeffectofaqueousextractofberberisvulgarislinamodelofparkinsonsdiseaseinrat AT mroghani neuroprotectiveeffectofaqueousextractofberberisvulgarislinamodelofparkinsonsdiseaseinrat AT mkamalinejad neuroprotectiveeffectofaqueousextractofberberisvulgarislinamodelofparkinsonsdiseaseinrat |
_version_ |
1717376569007144960 |